ORIGINAL
Efectos en vida real de la adición de semaglutida subcutánea semanal al tratamiento con insulina en diabetes mellitus tipo 2
Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus
J. Ares-Blancoa,b,c,
, P. Pujante-Alarcóna,b, C. Lambertb,d, P. Morales-Sánchezb,e, E. Delgado-Álvareza,b,c,e, E.L. Menéndez-Torrea,b,c,e
Corresponding author
a Servicio de Endocrinología y Nutrición, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
b Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Grupo ENDO, Oviedo, Asturias, España
c Departamento de Medicina, Universidad de Oviedo, Oviedo, Asturias, España
d Universidad de Barcelona, Barcelona, España
e Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), España
Read
943
Timeswas read the article
42
Total PDF
901
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 1 | 0 | 1 |
| 2025 6 | 6 | 0 | 6 |
| 2025 5 | 121 | 2 | 123 |
| 2025 4 | 138 | 3 | 141 |
| 2025 3 | 101 | 2 | 103 |
| 2025 2 | 64 | 2 | 66 |
| 2025 1 | 48 | 0 | 48 |
| 2024 12 | 78 | 2 | 80 |
| 2024 11 | 77 | 0 | 77 |
| 2024 10 | 37 | 2 | 39 |
| 2024 9 | 18 | 0 | 18 |
| 2024 8 | 18 | 0 | 18 |
| 2024 7 | 20 | 0 | 20 |
| 2024 6 | 10 | 0 | 10 |
| 2024 5 | 19 | 0 | 19 |
| 2024 4 | 20 | 0 | 20 |
| 2024 3 | 10 | 0 | 10 |
| 2024 2 | 10 | 0 | 10 |
| 2024 1 | 13 | 0 | 13 |
| 2023 12 | 22 | 0 | 22 |
| 2023 11 | 2 | 0 | 2 |
| 2023 7 | 3 | 2 | 5 |
| 2023 4 | 1 | 0 | 1 |
| 2023 3 | 25 | 10 | 35 |
| 2023 2 | 1 | 2 | 3 |
| 2023 1 | 2 | 1 | 3 |
| 2022 12 | 1 | 0 | 1 |
| 2022 11 | 14 | 6 | 20 |
| 2022 10 | 8 | 2 | 10 |
| 2022 9 | 2 | 2 | 4 |
| 2022 8 | 2 | 0 | 2 |
| 2022 7 | 5 | 2 | 7 |
| 2022 6 | 4 | 2 | 6 |
Show all
